May 31, 2018
Arix Biosciences director steps down
Arix Bioscience’s Non-Executive Director Lord Hutton is stepping down from his position, Arix said Thursday.
Pharmaceuticals, Biotechnology and Life Sciences
Arix Bioscience’s Non-Executive Director Lord Hutton is stepping down from his position, Arix said Thursday.
Arix Bioscience has raised $45 million by a Series B financing round for LogicBio Therapeutics, a new Arix Group Business focused on gene therapies for orphan paediatric diseases.